Comparison of NN1250 Versus Insulin Glargine in Subjects With Type 2 Diabetes
Status:
Completed
Trial end date:
2010-12-16
Target enrollment:
Participant gender:
Summary
This trial is conducted in Asia and Japan. The aim of this trial is to compare insulin
degludec (NN1250) with insulin glargine both combined with oral antidiabetic drugs (OADs) in
subjects with type 2 diabetes never treated with insulin.